ArticleOphthalmology and therapy2024

Understanding Perspectives on Presbyopia and Use of Pilocarpine HCl 1.25% Twice Daily from Participants of the Phase 3 VIRGO Study.

Brian M Shafer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.